Regentis Biomaterials RGNT
NYSE RGNT
$1.25 -0.02 (-1.58%)
As of: Nov 10, 2026 · 2:51 PM EST

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024)

Updated

Regentis Biomaterials' Total Non-Current Liabilities was $41.43 million in Q4 2024.

Analysis

Regentis Biomaterials (RGNT) Total Non-Current Liabilities (2024) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Thermo Fisher Scientific 265.71 Bn 242.23 Bn 5.13 Bn 54.88 Bn
2 Abbott Laboratories 189.37 Bn 163.23 Bn 7.39 Bn -
3 Danaher 164.78 Bn 144.43 Bn 3.84 Bn 33.44 Bn
4 Intuitive Surgical 157.85 Bn 138.13 Bn 2.08 Bn -
5 Medtronic 129.66 Bn 94.91 Bn 6.34 Bn 38.93 Bn
6 Stryker 121.82 Bn 108.01 Bn 4.25 Bn 20.68 Bn
7 Boston Scientific 63.42 Bn 58.86 Bn 3.43 Bn 17.15 Bn
8 Edwards Lifesciences 59.49 Bn 42.69 Bn 1.35 Bn 2.26 Bn
9 Becton Dickinson 58.38 Bn 55.53 Bn 2.32 Bn 23.92 Bn
10 Regentis Biomaterials 753,769.54 753,769.54 - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 41.43 Mn
API Access

Regentis Biomaterials Total Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=RGNT&period=max&api_key=YOUR_API_KEY